MENS
Jyong Biotech Ltd. Ordinary SharesNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$160.42M
P/E Ratio
—
EPS
$-0.04
Beta
—
52W High
$67.00
52W Low
$1.43
50-Day MA
$2.25
200-Day MA
$23.26
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Jyong Biotech Ltd. Ordinary Shares
Jyong Biotech Ltd. (ticker: MENS) is a forward-thinking biotechnology company dedicated to advancing therapeutic solutions for cancer and autoimmune diseases. Utilizing its expertise in genomics and molecular biology, the company has developed a robust pipeline of innovative treatments backed by a strong intellectual property portfolio. With strategic collaborations in the biopharmaceutical sector, Jyong Biotech aims to leverage emerging market opportunities while maintaining a focus on scientific rigor and patient-centered care, positioning itself as a significant contributor to the future of healthcare innovation.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-1.80M |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -5.44% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.31 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $74.23M |
| Float | $27.63M |
| % Insiders | 62.20% |
| % Institutions | 1.03% |
Historical Volatility
HV 10-Day
70.97%
HV 20-Day
80.42%
HV 30-Day
91.83%
HV 60-Day
121.15%
HV Rank
—
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 5/5/2026